TY  - GEN
AU  - Anraku,Tsutomu
AU  - Kuroki,Hiroo
AU  - Kazama,Akira
AU  - Bilim,Vladimir
AU  - Tasaki,Masaaki
AU  - Schmitt,Daniel
AU  - Mazar,Andrew
AU  - Giles,Francis J
AU  - Ugolkov,Andrey
AU  - Tomita,Yoshihiko
TI  - Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
SN  - 1791-244X
PY  - 2020///0911
KW  - Antineoplastic Agents
KW  - chemistry
KW  - Apoptosis
KW  - drug effects
KW  - Cell Cycle Checkpoints
KW  - Cell Line, Tumor
KW  - Glycogen Synthase Kinase 3 beta
KW  - antagonists & inhibitors
KW  - Humans
KW  - Kidney Neoplasms
KW  - drug therapy
KW  - Maleimides
KW  - Protein Kinase Inhibitors
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3892/ijmm.2019.4427
ER  -